How to inject corticosteroids (corticosteroid) in a patient with iliotibial (IT) band syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Inject Corticosteroids for Iliotibial Band Syndrome

For IT band syndrome, ultrasound-guided corticosteroid injection should target the space between the iliotibial band and the lateral femoral epicondyle, where bursal inflammation or fluid collection occurs, using strict aseptic technique with the patient positioned supine and the knee flexed at 30 degrees.

Indications for Injection

Corticosteroid injections are indicated when:

  • Visible swelling or pain with ambulation persists for more than 3 days after initiating conservative treatment 1
  • Symptoms are recurrent or refractory to initial conservative management 2
  • The patient has failed rest, stretching, physical therapy, and anti-inflammatory medications 1, 3

Pre-Injection Requirements

Patient Preparation

  • Obtain informed consent documenting the nature of the procedure, potential benefits, and risks according to local protocols 4
  • Position the patient supine on an examination table with the affected knee flexed at approximately 30 degrees—this is the position where maximum tenderness occurs and optimal access to the inflamed bursa is achieved 5
  • Ensure the setting is professional, clean, quiet, private, and well-lit 4

Special Populations

  • Diabetic patients must be counseled about transient hyperglycemia risk, particularly days 1-3 post-injection, and advised to monitor glucose levels closely 4
  • Pregnant patients can receive local corticosteroid injections as the benefit/risk ratio may be superior to systemic therapy 4
  • Patients on anticoagulation or with bleeding disorders can receive injections unless bleeding risk is high 4

Injection Technique

Imaging Guidance

  • Ultrasound guidance is strongly recommended to improve accuracy and ensure proper placement between the iliotibial band and lateral femoral epicondyle 4, 2
  • Ultrasound findings to identify include soft-tissue edematous swelling or discrete fluid collection suggestive of bursitis between the IT band and lateral femoral epicondyle 2
  • While landmark-guided injections can be performed, ultrasound improves accuracy and allows visualization of the target pathology 4

Aseptic Technique (Mandatory)

  • Use surgical gloves 4
  • Prepare skin with alcohol, iodine disinfectant, or chlorhexidine 4
  • Change needles between drawing the medication and injecting into the tissue 4
  • Have resuscitation equipment nearby 4

Local Anesthesia

  • Offer local anesthetic after explaining pros and cons 4
  • Options include topical anesthetic (ethyl chloride spray) or subcutaneous infiltration along the needle path 4
  • Warmed local anesthetic (37°C) reduces infiltration pain compared to room temperature 4

Corticosteroid Selection and Dosing

  • Methylprednisolone acetate is the most commonly used formulation for soft tissue injections 6, 7
  • Alternative options include triamcinolone acetonide 6
  • The injection targets the bursal space or area of inflammation between the IT band and lateral femoral epicondyle, not into the band itself 2, 5

Injection Procedure

  1. Identify the point of maximal tenderness over the lateral femoral epicondyle with the knee at 30 degrees flexion 5
  2. Under ultrasound guidance, advance the needle to the space between the IT band and the lateral epicondyle 2
  3. Aspirate if fluid collection is visible to confirm needle placement 4
  4. Inject the corticosteroid slowly into the bursal space 5

Post-Injection Care

Immediate Instructions

  • Avoid overuse of the injected area for 24 hours following injection 4
  • Immobilization is discouraged—gentle range of motion is acceptable 4
  • Patients may eat and drink immediately after the procedure 8

Activity Modification

  • Continue activity modification and training regimen adjustments 1, 3
  • Maintain stretching of the iliotibial band and strengthening of the gluteus medius 1
  • Address training irregularities including distance, speed, terrain, surface, and footwear 3

Monitoring and Follow-Up

  • Most patients with IT band syndrome respond within days to weeks when injection is combined with activity modification 1, 3
  • Symptoms often persist 2-6 months without proper treatment 3
  • Re-injection decisions should consider benefits from previous injections, treatment alternatives, and individual factors 4
  • A small percentage of patients are refractory to conservative treatment including injections and may require surgical release of the posterior fibers of the IT band 1, 5

Critical Pitfalls to Avoid

  • Never inject into an infected site—rule out septic process before injection 7
  • Do not inject directly into the IT band itself; target the bursal space beneath it 2
  • Avoid repeated injections without addressing underlying biomechanical factors and training errors 1, 3
  • Do not use corticosteroids as first-line treatment before attempting conservative measures 1
  • Be aware that systemic absorption can occur even with local injection, particularly with larger doses 7

References

Research

Iliotibial band syndrome: a common source of knee pain.

American family physician, 2005

Research

Ultrasound of iliotibial band syndrome.

Journal of ultrasound, 2020

Research

Iliotibial band syndrome in distance runners.

Sports medicine (Auckland, N.Z.), 1985

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The treatment of iliotibial band friction syndrome.

British journal of sports medicine, 1979

Guideline

Systemic Steroid Injections for Dermatological Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Post-Procedural Care After Intratympanic Steroid Injection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is performing a corticosteroid (corticosteroid) injection for iliotibial band syndrome without ultrasound guidance dangerous?
What is the diagnosis and recommended treatment for a adult patient with no significant past medical history, presenting with lateral knee pain that radiates up and down, worsens with activity such as walking and standing, and improves with rest, who has been experiencing symptoms for a month after stepping over a stone while walking, with alleviating factors including rest and Tylenol (acetaminophen) but not Diclofenac, and denies direct trauma, fall, tingling/numbness, lower back pain, knee swelling, knee buckling/catching, and nighttime pain?
What is the most likely diagnosis for a runner with knee pain and localized tenderness to the lateral aspect of the knee?
What is the best treatment approach for an elderly male with persistent iliotibial (IT) band pain and quadriceps pain causing knee pain that did not respond to intra-articular joint injection?
What is the treatment for a patient with iliotibial (IT) band syndrome presenting with knee pain and tenderness on the lateral aspect of the knee, exacerbated by passive flexion?
Can an elderly patient with dementia stop taking trospium (antimuscarinic for overactive bladder) abruptly?
What is the most common cause of lateral knee pain that is extremely tender when kneeling?
What is the recommended dosing for magnesium replacement in a patient with a magnesium deficiency, considering factors such as age, weight, and underlying medical conditions like impaired renal function?
What is the recommended dose adjustment for a patient on 225 µg of Synthroid (levothyroxine) with a TSH level of 0.13 mIU/L?
Is performing a corticosteroid (corticosteroid) injection for iliotibial band syndrome without ultrasound guidance dangerous?
Is a modified natural cycle Frozen Embryo Transfer (FET) feasible in a female patient of reproductive age with premature ovarian failure (POF) and a history of infertility?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.